MedTrace Logo

Post-operative Pain Reduction

NCT04338633 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-08

No results posted yet for this study

Summary

Recruited patients with necrotic pulp after application of conventional calcium hydroxide paste are assigned to group, Calcium hydroxide nanoparticle group and Combined Calcium hydroxide with silver nanoparticle group and record postoperative pain afterwards.

Conditions

  • Effects of the Elements

Interventions

DRUG

Conventional calcium hydroxide paste

Conventional calcium hydroxide paste (Ultracal) will be removed in second visit.

DRUG

Calcium hydroxide nanoparticle

Calcium hydroxide nanoparticle. manufactured in NanoTech. institute, will be removed in second visit.

DRUG

Combined Calcium hydroxide with silver nanoparticle

Combined Calcium hydroxide with silver nanoparticle will be removed in second visit.

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Magdy Mohamed Aly, Professor · Dean of Faculty

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04338633 on ClinicalTrials.gov